Catalyst Event
Regeneron Pharmaceuticals Inc (REGN) · Earnings Release
From Akros SCHK HK-US Biotech Index (ASHUBIO)
4/29/2026, 12:00:00 AM
Regeneron is scheduled to report its first quarter 2026 financial and operating results on 2026-04-29. Importance is Medium as earnings typically drive significant price movement, scheduled.
Korean Translation
리제네론, 2026년 4월 29일 2026년 1분기 재무 및 운영 실적 발표 예정임. 실적 발표는 통상적으로 주가에 유의미한 영향을 미치므로 중요도를 Medium으로 예상됨.
Related Recent Events
CSPC Pharmaceutical Group Ltd (1093) · Other
Final dividend of HKD 0.15 per share for FY2025 (total HKD 0.29, +11.5% YoY) with ex-dividend date June 24, 2026; low importance as dividend increases typically result in minor positive price adjustments scheduled.
6/24/2026, 12:00:00 AM
Pfizer Inc (PFE) · Earnings Release
High importance is estimated due to the potential for significant price volatility for Pfizer's Q1 2026 earnings release and conference call, scheduled.
5/5/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release and conference call scheduled; typically results in moderate price movement.
4/30/2026, 12:00:00 AM
Bristol-Myers Squibb Co (BMY) · Earnings Release
Q1 2026 earnings release and conference call scheduled.
4/30/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Earnings Release
Q1 2026 earnings release and conference call for 2026-04-30, estimated to have a low impact of ~1-2% based on historical trends, scheduled.
4/30/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Abbott Laboratories is scheduled to announce its first-quarter 2026 financial results before the market opens on April 16, 2026, scheduled.
4/16/2026, 12:00:00 AM